FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Harry Holzmüller

Research Profile

Procedures

Chemicals & Drugs

Physiology

Living Beings

Anatomy

Disorders

Brain Infarction

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Juraj Hlavaty; Harry Holzmüller; Gerrit Jandl; Helga Petznek; André Berger; Walter H Günzburg; Brian Salmons; Angelika Url; Matthias Renner
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer.
Johannes Lengler; Markus Omann; Dana Düvier; Harry Holzmüller; Wolfgang Gregor; Brian Salmons; Walter H Günzburg; Matthias Renner
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Johannes Lengler; Harry Holzmüller; Brian Salmons; Walter H Günzburg; Matthias Renner
FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Harry Holzmüller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2012: Juraj Hlavaty; Harry Holzmüller; Gerrit Jandl; Helga Petznek; André Berger; Walter H Günzburg; Brian Salmons; Angelika Url; Matthias Renner
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer.
PloS one 2012;7(7):e40611.
2006: Johannes Lengler; Markus Omann; Dana Düvier; Harry Holzmüller; Wolfgang Gregor; Brian Salmons; Walter H Günzburg; Matthias Renner
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Biochemical pharmacology 2006;72(7):893-901.
2005: Johannes Lengler; Harry Holzmüller; Brian Salmons; Walter H Günzburg; Matthias Renner
FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein.
Analytical biochemistry 2005;343(1):116-24.
2002: Ertugrul Kilic; Dirk M Hermann; Sebastian Kügler; Ulkan Kilic; Harry Holzmüller; Christian Schmeer; Mathias Bähr
Adenovirus-mediated Bcl-X(L) expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice.
Neurobiology of disease 2002;11(2):275-84.
2001: Sebastian Kügler; L Meyn; Harry Holzmüller; Ellen Gerhardt; Stefan Isenmann; Jörg B Schulz; Mathias Bähr
Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors.
Molecular and cellular neurosciences 2001;17(1):78-96.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.